First person: Antoni Ribas, MD, PhD: The physician-scientist from the University of California at Los Angeles researches how new therapies for patients with advanced malignant melanoma can help to overcome resistance to treatment.

Subjects

Subjects :

Antineoplastic Agents, Immunological pharmacology
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Costimulatory and Inhibitory T-Cell Receptors antagonists & inhibitors
Costimulatory and Inhibitory T-Cell Receptors immunology
Drug Resistance, Neoplasm immunology
History, 20th Century
History, 21st Century
Humans
Los Angeles
Medical Oncology methods
Melanoma immunology
Melanoma pathology
Physicians history
Skin Neoplasms immunology
Skin Neoplasms pathology
Treatment Outcome
Antineoplastic Agents, Immunological therapeutic use
Antineoplastic Combined Chemotherapy Protocols pharmacology
Drug Resistance, Neoplasm drug effects
Melanoma drug therapy
Skin Neoplasms drug therapy

Details

Language :

English

ISSN :

1097-0142

Volume :

124

Issue :

6

Database :

MEDLINE

Journal :

Cancer

Publication Type :

Periodical

Accession number :

29509327

Full Text :

https://doi.org/10.1002/cncr.31300